This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Introduction: Home noninvasive ventilation (NIV) is increasingly used in ALS to improve symptoms and survival. Our primary objective was to compare iVAPS vs. ST modes regarding time to first change in ventilator parameters and the number of interventions over 6 months in subjects with ALS in a respiratory therapist (RT)-led program.
Methods: In this study, 30 subjects with ALS meeting criteria for NIV initiation were randomized to iVAPS or ST. NIV was initiated using standardized protocols targeting optimal tidal volume and comfort in a daytime session. “Download” data was recorded at 1 week, 1 and 6 months. Any changes in ventilator parameters were recorded.
Results: Of the 30 subjects, 56.7% had bulbar onset ALS, 8 died and 11 in each group completed the study. Median time to first parameter change was 33.5 (IQR:7.7-96) vs. 41 (IQR: 12.5-216.5) days for iVAPS vs. ST groups, respectively (P = 0.48). The average number of RT interventions was similar between groups (1.1±1.1 vs 0.9±0.9 at 1 month, P = 0.72; 2.4±2.1 vs 2.4±2.3 at 6 months, P = 0.95; for iVAPS vs ST respectively). Adherence was significantly lower with iVAPS than ST at 1 week, but not at 1 or 6 months. Download parameters were similar between groups at 1 week and 6 months, except for higher residual apnea-hypopnea index (AHI) and less spontaneously triggered breaths with iVAPS at 6 months.
Conclusions: The time to first change of parameters and the number of interventions at 6 months from NIV initiation were similar for the iVAPS and ST modes in subjects with ALS. With iVAPS, adherence was lower transiently at NIV initiation, and the residual AHI was higher at 6 months. Alveolar ventilation-targeted NIV may require a longer adaptation period and result in greater upper airway instability in predominantly bulbar ALS subjects.
- noninvasive ventilation (NIV)
- intelligent volume-assured pressure support (iVAPS)
- bilevel spontaneous timed ventilation
- amyotrophic lateral sclerosis (ALS)
- respiratory therapist interventions
- apnea hypopnea index
Footnotes
- Address for correspondence:
Pattaraporn Panyarath, MD, McGill University Health Centre, Respiratory Division/Sleep laboratory, 1001 Decarie Blvd, Montreal, Qc, Canada, H4A 3J1, pattaraporn.panyarath{at}mail.mcgill.ca - Marta Kaminska, MD, M.Sc. FRCP(C), McGill University Health Centre, Respiratory Division/Sleep laboratory, 1001 Decarie Blvd, Montreal, Qc, Canada, H4A 3J1, tel: 514–934-1934 ext 32117, fax: 514–843-1695, marta.kaminska{at}mcgill.ca
- Received August 25, 2021.
- Accepted February 28, 2022.
- Copyright © 2022 by Daedalus Enterprises
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Log in using your username and password
